The Recall Desk
ModerateFDA (Devices)·Z-1035-2017·Announced 2017-01-25

Endologix AFX Endovascular AAA System Clinical Data Correction

Endologix is correcting cumulative clinical data reports for the AFX Endovascular AAA System and Powerlink System. This action applies to procedures conducted after June 2013.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The source describes a correction to clinical data reports without mentioning specific physical hazards, injuries, or illnesses, fitting the criteria for a voluntary precautionary or documentation-related recall.

Plain-English summary

Endologix has initiated a correction to update reports containing cumulative clinical data and information for the AFX Endovascular AAA System and the Powerlink System. This recall is not lot-specific and applies to AFX procedures conducted after June 2013.

The affected products were distributed worldwide, including in the United States and various countries in Europe and the Middle East. The source text does not specify a particular hazard, injury, or illness associated with this correction.

Consumers and healthcare providers should refer to the official FDA recall notice for specific instructions on how to handle this data correction.

The recalled product

Product
AFX Endovascular AAA System, Endoleak Type IIIA
Manufacturer
Endologix
Affected units
40,967

Distribution

Distribution scope not specified by the agency.